Scope
The IAP chapter explains the different purposes of India’s National Immunisation Programme and the IAP individual-child schedule. The available text identifies additional IAP options and the rationale for following scheduled doses. The age-by-vaccine and catch-up tables are not reproduced in this summary.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Distinguish public and individual-child schedules
- Explain that the national programme provides essential vaccines free through government facilities, whereas the IAP schedule focuses on individual-child protection and includes additional options, generally available privately at a cost. [1]
- The IAP schedule includes the vaccines in the national schedule and considers the individual child’s risk when adding vaccines. It may recommend additional doses or different timings based on evidence; the two schedules should not be treated as interchangeable tables. [1]
- Follow the recommended schedule to obtain the intended protection. Multiple priming doses in infancy address immune immaturity and interference from maternal antibodies; they are part of the schedule’s design rather than redundant doses. [1]
Additional IAP options described in the chapter
- The additional-options list includes influenza vaccination up to 5 years of age, hepatitis A, varicella, MMR for mumps coverage, typhoid conjugate vaccine and Tdap. The corresponding product, age and interval tables must be consulted before prescribing a schedule. [1]
- The chapter lists HPV vaccination for adolescent girls and boys, while meningococcal conjugate vaccination is reserved for specified high-risk conditions and situations. [1]
- RSV monoclonal antibodies are listed for preterm infants within high-risk newborn and infant prevention; the text does not supply a complete eligibility or dosing schedule for this option. [1]
Limitations and use
- The main national and IAP schedule tables, comparison table, and catch-up schedules are not available as usable recommendation text here; this summary cannot be used to assign vaccine ages, intervals, doses or catch-up timing.
- Eligibility and product-specific details of the additional vaccines and RSV antibodies need the complete current schedule.
- This chapter’s discussion of national and private schedules does not establish local stock, funding or availability for an individual patient.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Immunization Schedules – NIP & IAP
Selected recommendation material consulted
Publication details
- Issuing organisation
- IAP
- Resource type
- Practice guideline · House clinical summary
- Source setting
- India
Earlier House summaries: childhood immunisation schedule iap
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.